ISARNA THERAPEUTICS
Isarna Therapeutics has an unmatched commitment to developing selective TGF-ฮฒ inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
ISARNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
1998-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.isarna-therapeutics.com
Total Employee:
11+
Status:
Active
Contact:
49 89 890831 0
Total Funding:
124.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Current Advisors List
Current Employees Featured
Founder
Investors List
Global Asset Fund
Global Asset Fund investment in Venture Round - Isarna Therapeutics
MIG
MIG investment in Venture Round - Isarna Therapeutics
AT Impf
AT Impf investment in Venture Round - Isarna Therapeutics
MIG
MIG investment in Venture Round - Isarna Therapeutics
Global Asset Fund
Global Asset Fund investment in Venture Round - Isarna Therapeutics
MIG
MIG investment in Venture Round - Isarna Therapeutics
Global Asset Fund
Global Asset Fund investment in Venture Round - Isarna Therapeutics
MIG
MIG investment in Venture Round - Isarna Therapeutics
MIG
MIG investment in Venture Round - Isarna Therapeutics
Global Asset Capital
Global Asset Capital investment in Private Equity Round - Isarna Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-09-30 | Isarna Therapeutics Appoints Claus Schalper as CEO |
Official Site Inspections
http://www.isarna-therapeutics.com
- Host name: sh20024.ispgateway.de
- IP address: 92.205.54.255
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin